Fda, Herceptin | featured news

Welcome to Wopular's coverage of Fda, Herceptin. Wopular aggregates news headlines from the top newspapers and news sources. To the right are articles about Fda, Herceptin that have been featured on main sections of the site.

Below are topics about Fda, Herceptin. (Click on "all" to view all articles related to the topic, including articles NOT about Fda, Herceptin.

Click here to search news sites, aggregators, and blogs as well as videos, photos, and websites about Fda, Herceptin.

Bookmark or Share

Main Topics

Fda Topics

FDA approves new targeted breast cancer drug

Roche

The Food and Drug Administration says it has approved a new form of a best-selling breast cancer drug that targets tumor cells while sparing healthy ones. The drug Kadcyla (kad-SY'-luh) from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a double-shot of anti-tumor poison.

 

Subscribe to this RSS topic: Syndicate content